Oxygenta Pharmaceutical Ltd

BSE :524636 NSE :- Sector : Pharmac..
82.56
Change: -1.68(-1.99%)
No Graph Available
52 week Low
27.62
52 week High
108.64
Day low
82.56
Day high
82.60
Prev Close
84.24
Open
82.60
6M return
129.84%
1Y return
159.46%
MCap(Rs. in Cr.)
305.34
Total Volume
7,845
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
NM
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
-0.10
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
-16.16
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
100%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
-34.50%

Sales Industry Avg
2.98%

PAT
470.49%

PAT Industry Avg
-38.30%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales33.2114.0112.6210.5539.64
Gross Profit-4.26-2.11-2.17-1.95-11.21
Operating Profit00000
Profit Before Tax-3.93-2.85-1.368.02-13.87
Tax0000-10.39
Profit After Tax-3.93-2.85-1.368.02-3.48
No data available
No data available


Relative to Sensex rtn in 3 year
684.48%

Relative to Nifty rtn in 3 year
649.66%



1 Year (%)2 Year (%)3 Year (%)
Oxygenta Pharma159228244
Bse Sensex42531
Nifty 5042833

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Oxygenta Pharma
82.56
Change: -1.68 (-1.99%)
1 Year return
159.46%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
305.34
Shukra Pharma.
205.60
Change: 3.05 (1.51%)
1 Year return
319.08%
Risk (Std Dev)
0.48%
PE Ratio
109.95
MCap( in Cr.)
900.28
Everest Organics
243.65
Change: -12.80 (-4.99%)
1 Year return
78.89%
Risk (Std Dev)
0.35%
PE Ratio
NM
MCap( in Cr.)
249.03
Pharmaids Pharma
61.94
Change: 0.00 (0.00%)
1 Year return
19.83%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
218.45
Syschem (India)
43.01
Change: -0.97 (-2.21%)
1 Year return
-29.71%
Risk (Std Dev)
0.12%
PE Ratio
NM
MCap( in Cr.)
175.32
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 2,59,459.50 with a Gain of 159.46%

News

Stay tuned to the latest developments and happenings in the company.

Oxygenta Pharmaceutical reports standalone net loss of Rs 3.93 crore in the December 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 3.93 crore in the quarter ended December 2024 as against net loss of Rs 3.78 crore during the previ....

15 Feb 2025 07:32

Oxygenta Pharmaceutical to convene board meeting

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live....

11 Feb 2025 14:01

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live....

10 Feb 2025 10:03

Oxygenta Pharmaceutical reports standalone net loss of Rs 2.85 crore in the September 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 2.85 crore in the quarter ended September 2024 as against net loss of Rs 3.16 crore during the prev....

15 Nov 2024 07:44

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live ....

11 Nov 2024 11:06

Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as against net loss of Rs 4.56 crore during the previous ....

16 Aug 2024 07:38

View More
Subscribe for our
newsletter
Open Account Now